Home
ICUCW
ICUCW News

Latest SeaStar Medical Holding Corporation Warrant (ICUCW) News on July 2, 2025

MT Newswires

6 days ago

Top Midday Gainers

SeaStar Medical Reports Update on Nasdaq Listing Status

GlobeNewswire

7 days ago

SeaStar Medical Reports Update on Nasdaq Listing Status

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

GlobeNewswire

8 days ago

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

MT Newswires

11 days ago

Sector Update: Health Care

MT Newswires

11 days ago

Top Midday Decliners

MT Newswires

11 days ago

SeaStar Medical Prices Offering to Raise Up to $8 Million

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

GlobeNewswire

11 days ago

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research

GlobeNewswire

21 days ago

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs

GOBankingRates

a month ago

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs

3 International Vacations That Are Cheaper Than an iPhone

GOBankingRates

a month ago

3 International Vacations That Are Cheaper Than an iPhone

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck

GOBankingRates

a month ago

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck

This week in Trumponomics: Too bad TACO isn’t true

Yahoo Finance

a month ago

This week in Trumponomics: Too bad TACO isn’t true

Starmer says Farage would spook the City and give us Truss 2 – he could be right

The Guardian

a month ago

Starmer says Farage would spook the City and give us Truss 2 – he could be right

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Yahoo Finance Video

a month ago

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?

Benzinga

a month ago

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?

Ford recalls more than 29,000 vehicles in the US, NHTSA says

Reuters

a month ago

Ford recalls more than 29,000 vehicles in the US, NHTSA says

SeaStar Q1 Results: QUELIMMUNE Sales Up Fourfold Sequentially, Company Now Targeting Adult Market

NewMediaWire

a month ago

SeaStar Q1 Results: QUELIMMUNE Sales Up Fourfold Sequentially, Company Now Targeting Adult Market

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

GlobeNewswire

a month ago

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

GuruFocus.com

2 months ago

SeaStar Medical Holding Corp (ICU) Q1 2025 Earnings Call Highlights: Revenue Surge and ...

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

GlobeNewswire

2 months ago

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

GlobeNewswire

2 months ago

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

GlobeNewswire

2 months ago

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

GlobeNewswire

2 months ago

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

GlobeNewswire

3 months ago

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Thomson Reuters StreetEvents

3 months ago

Q4 2024 SeaStar Medical Holding Corp Earnings Call

GuruFocus.com

3 months ago

SeaStar Medical Holding Corp (ICU) Q4 2024 Earnings Call Highlights: Strategic Advances Amidst ...

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

GlobeNewswire

3 months ago

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

GlobeNewswire

3 months ago

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

PR Newswire

3 months ago

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

GlobeNewswire

5 months ago

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market

GlobeNewswire

5 months ago

SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market

SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE

GlobeNewswire

5 months ago

SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE

Mayo Clinic joins SeaStar Medical for acute kidney injury trial

Medical Device Network

5 months ago

Mayo Clinic joins SeaStar Medical for acute kidney injury trial

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

GlobeNewswire

5 months ago

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

SeaStar Medical says FDA approves feasibility study with SCD-ADULT

TipRanks

6 months ago

SeaStar Medical says FDA approves feasibility study with SCD-ADULT

MT Newswires

6 months ago

SeaStar Medical Says FDA Approved Study on Selective Cytopheretic Device in Cardiorenal Syndrome

FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

GlobeNewswire

6 months ago

FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

GlobeNewswire

6 months ago

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

GlobeNewswire

6 months ago

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

GlobeNewswire

7 months ago

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

GlobeNewswire

7 months ago

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial

GlobeNewswire

7 months ago

SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial

SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024

GlobeNewswire

7 months ago

SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

GlobeNewswire

7 months ago

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

GlobeNewswire

8 months ago

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire

8 months ago

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update

FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis

GlobeNewswire

8 months ago

FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis

Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial

GlobeNewswire

8 months ago

Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial

SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE

GlobeNewswire

8 months ago

SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update

GlobeNewswire

8 months ago

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024

GlobeNewswire

8 months ago

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024

SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial

GlobeNewswire

8 months ago

SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers

GlobeNewswire

8 months ago

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers

SeaStar hits halfway mark in AKI trial for selective cytopheretic device

Medical Device Network

8 months ago

SeaStar hits halfway mark in AKI trial for selective cytopheretic device

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

GlobeNewswire

8 months ago

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week

GlobeNewswire

9 months ago

SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week

SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit

GlobeNewswire

9 months ago

SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit

SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities

GlobeNewswire

9 months ago

SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities

SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial

GlobeNewswire

9 months ago

SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial

SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference

GlobeNewswire

10 months ago

SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference

SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt

GlobeNewswire

10 months ago

SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt

MT Newswires

a year ago

Top Premarket Decliners

SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire

a year ago

SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s

GlobeNewswire

a year ago

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s

MT Newswires

a year ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

MT Newswires

a year ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

MT Newswires

a year ago

SeaStar Medical Treats First Pediatric Patient in Commercial Setting With Kidney Drug

First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device

GlobeNewswire

a year ago

First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s

GlobeNewswire

a year ago

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s

CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial

GlobeNewswire

a year ago

CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial

MT Newswires

a year ago

Sector Update: Health Care

MT Newswires

a year ago

SeaStar Medical Begins Commercial Sale of Pediatric Acute Kidney Injury Treatment

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner

GlobeNewswire

a year ago

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner

SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

a year ago

SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

MT Newswires

a year ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

MT Newswires

a year ago

SeaStar Medical Launching $10 Million Direct Offering -- Shares Fall

SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

a year ago

SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

MT Newswires

a year ago

SeaStar Medical Says US FDA Agrees to Final Labeling for Quelimmune

SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device

GlobeNewswire

a year ago

SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology

GlobeNewswire

a year ago

SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology

Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now

SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company

GlobeNewswire

a year ago

SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company

Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation

GlobeNewswire

a year ago

Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation

SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024

GlobeNewswire

a year ago

SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024

SeaStar Medical Announces 25-for-1 Reverse Stock Split

GlobeNewswire

a year ago

SeaStar Medical Announces 25-for-1 Reverse Stock Split

Seastar touts positive case studies for selective cytopheretic device

Medical Device Network

a year ago

Seastar touts positive case studies for selective cytopheretic device

Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility

GlobeNewswire

a year ago

Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility

SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire

a year ago

SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update

SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure

GlobeNewswire

a year ago

SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure

SeaStar Medical Reports 2023 Financial Results and Provides a Business Update

GlobeNewswire

a year ago

SeaStar Medical Reports 2023 Financial Results and Provides a Business Update

SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference

GlobeNewswire

a year ago

SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference

SeaStar Medical to Restate Financials, Sets Business Update Call for April 17

GlobeNewswire

a year ago

SeaStar Medical to Restate Financials, Sets Business Update Call for April 17

SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients

GlobeNewswire

a year ago

SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients

SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024

GlobeNewswire

a year ago

SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024

Thomson Reuters StreetEvents

a year ago

Q4 2023 Nuwellis Inc Earnings Call

Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure

GlobeNewswire

a year ago

Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure

Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™

GlobeNewswire

a year ago

Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™

FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury

GlobeNewswire

a year ago

FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury

Unleash Massive Returns With These 3 Top Penny Stocks

InvestorPlace

a year ago

Unleash Massive Returns With These 3 Top Penny Stocks

Share on Social Networks: